Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Change in Receivables: 2009-2024

Historic Change in Receivables for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$128.3 million.

  • Cross Country Healthcare's Change in Receivables fell 65068.69% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.9 million, marking a year-over-year increase of 5993.74%. This contributed to the annual value of -$128.3 million for FY2024, which is 4896.05% up from last year.
  • As of FY2024, Cross Country Healthcare's Change in Receivables stood at -$128.3 million, which was up 4896.05% from -$251.4 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Change in Receivables peaked at $318.4 million during FY2021, and registered a low of -$251.4 million during FY2023.
  • In the last 5 years, Cross Country Healthcare's Change in Receivables had a median value of $4.7 million in 2020 and averaged $19.3 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 661064.28% in 2021, then tumbled by 26408.58% in 2023.
  • Over the past 5 years, Cross Country Healthcare's Change in Receivables (Annual) stood at $4.7 million in 2020, then soared by 6610.64% to $318.4 million in 2021, then plummeted by 51.88% to $153.2 million in 2022, then tumbled by 264.09% to -$251.4 million in 2023, then soared by 48.96% to -$128.3 million in 2024.
  • Its Change in Receivables stands at -$128.3 million for FY2024, versus -$251.4 million for FY2023 and $153.2 million for FY2022.